Cargando…
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms (including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon according to large multinational cohorts, including against isolates resistant to carbapenems, ceftazidime/avibactam, ceftolozane/...
Autores principales: | Karakonstantis, Stamatis, Rousaki, Maria, Kritsotakis, Evangelos I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220290/ https://www.ncbi.nlm.nih.gov/pubmed/35740130 http://dx.doi.org/10.3390/antibiotics11060723 |
Ejemplares similares
-
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems
por: Karakonstantis, Stamatis, et al.
Publicado: (2020) -
Editorial for the Special Issue: “Epidemiology, Prognosis and Antimicrobial Treatment of Extensively Antibiotic-Resistant Bacterial Infections”
por: Karakonstantis, Stamatis, et al.
Publicado: (2022) -
Co-isolates of Acinetobacter baumannii complex in polymicrobial infections: a meta-analysis
por: Karakonstantis, Stamatis, et al.
Publicado: (2022) -
P35 Heteroresistance to cefiderocol in clinical Gram-negative isolates
por: Watson, Celeste, et al.
Publicado: (2023) -
Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii
por: Karakonstantis, Stamatis, et al.
Publicado: (2021)